The Global Antibiotic Resistance Market is estimated to be valued at US$ 8.83 Bn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 To 2031 driven by increased R&D investments and fast-track approvals by regulatory bodies for new drugs to combat antibiotic resistance.Key TakeawaysKey players operating in the Global Antibiotic Resistance are Melinta Therapeutics,...
0 Commentarios
0 Acciones
562 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian